The Federal Aviation Administration (FAA) five-year reauthorization was signed into law on May 16, 2024. The legislation now includes a provision that mandates airlines to carry epinephrine specifically intended for treating anaphylaxis in all on-board first aid kits. This is a significant victory for allergists and allergy advocacy organizations, such as the American College of Allergy, Asthma and Immunology (ACAAI) and its Advocacy Council, who have been lobbying Congress for this change for many years.
